Medical Director, Pharmacovigilance
Deciphera Pharmaceuticals
About this role
Deciphera is seeking a Medical Director to lead global pharmacovigilance activities for marketed and investigational products, focusing on safety data analysis, risk assessment, and safety communication. The role involves collaborating with cross-functional teams, supporting safety and regulatory processes, and representing the company in safety-related meetings.
Skills
Qualifications
About Deciphera Pharmaceuticals
deciphera.comDeciphera Pharmaceuticals is a biopharmaceutical company dedicated to discovering, developing, and commercializing targeted small‑molecule therapies to improve outcomes for people with cancer. The company focuses on precision oncology and kinase switch‑control inhibitors, including the approved therapy QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor (GIST), along with multiple preclinical and clinical‑stage programs. Driven by a patient‑inspired mission, Deciphera collaborates with academic and industry partners and engages patient communities to translate novel science into meaningful treatments.
About Deciphera Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
Salary
$228k – $313k
per year
More jobs at Deciphera Pharmaceuticals
Similar Jobs
Pharmacovigilance Medical Director
Integrated Resources INC
Sr. Medical Director, Gastrointestinal and Inflammation (Remote)
Takeda Pharmaceutical Company
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
IQVIA
Senior Manager, Pharmacovigilance
American Regent
Safety Data Lead I
MSD
Executive Medical Director, Pharmacovigilance
Sarepta Therapeutics